Physician profile
David R Axline
NPI 1023002003
$10,847.87
in general payments reported to CMS, 2019-2025
19 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $149 · 2021: $1,120 · 2022: $1,879 · 2023: $3,002 · 2024: $3,440 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,329 · Travel and Lodging: $3,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,329.08 |
| Travel and Lodging | $3,217.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,180.34 | 2019-2024 | Amplatzer Amulet, Absolute Pro, Mitraclip |
| Boston Scientific Corporation | $1,781.90 | 2019-2025 | Watchman Flx, Farapulse |
| Edwards Lifesciences Corporation | $1,268.48 | 2021-2025 | Pascal |
| Medtronic, INC. | $736.25 | 2022-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.94 | 2021-2025 | Lifevest |
| Abiomed | $362.65 | 2021-2024 | Impella |
| Shockwave Medical, INC | $297.72 | 2021-2025 | |
| Cvrx, INC. | $203.44 | 2023-2025 | Barostim Neo System |
| Zoll Circulation INC | $168.50 | 2025 | Catheter, Temperature Management System, Temperature Management System Start-Up Kit |
| Cardiva Medical, INC. | $99.91 | 2021 | |
| Impulse Dynamics (USA) INC. | $84.98 | 2022 | |
| Amgen INC. | $59.88 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $56.40 | 2023-2024 | |
| Cleerly, INC. | $34.24 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Astrazeneca Pharmaceuticals LP | $31.88 | 2023-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $28.81 | 2025 | |
| Novo Nordisk INC | $23.30 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.53 | 2022 | |
| Chiesi USA, INC. | $17.72 | 2025 | Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Axline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.